Immune Checkpoints and Innate Lymphoid Cells—New Avenues for Cancer Immunotherapy

SIMPLE SUMMARY: Targeting the inhibitory receptors expressed by immune cells has revolutionized the clinical management of cancer patients. Initially developed to enhance T cell responses, recent investigations have demonstrated that innate lymphoid cells (ILC) also express many of these checkpoint...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacquelot, Nicolas, Ghaedi, Maryam, Warner, Kathrin, Chung, Douglas C., Crome, Sarah Q., Ohashi, Pamela S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657134/
https://www.ncbi.nlm.nih.gov/pubmed/34885076
http://dx.doi.org/10.3390/cancers13235967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657134/
https://www.ncbi.nlm.nih.gov/pubmed/34885076
http://dx.doi.org/10.3390/cancers13235967

Ejemplares similares